Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, February 28, 2022
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
[ Mon, Feb 28th 2022
] - WOPRAI
Sun, February 27, 2022
[ Sun, Feb 27th 2022
] - WOPRAI
[ Sun, Feb 27th 2022
] - WOPRAI
Fri, February 25, 2022
[ Fri, Feb 25th 2022
] - WOPRAI
[ Fri, Feb 25th 2022
] - WOPRAI
[ Fri, Feb 25th 2022
] - WOPRAI
[ Fri, Feb 25th 2022
] - WOPRAI
Chris Howerton Downgraded (VNDA) to Hold and Decreased Target to $12 on, Feb 25th, 2022
Chris Howerton of Jefferies, Downgraded "Vanda Pharmaceuticals Inc." (VNDA) to Hold and Decreased Target from $24 to $12 on, Feb 25th, 2022.
Chris, nor any peers, have made any analyst calls on VNDA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30